We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+14.11%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$944M
AUM Growth
+$119M
Cap. Flow
+$5.3M
Cap. Flow %
0.56%
Top 10 Hldgs %
30.12%
Holding
256
New
19
Increased
59
Reduced
92
Closed
3

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.03M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.6M
3
WAB icon
Wabtec
WAB
+$2.09M
4
MPC icon
Marathon Petroleum
MPC
+$1.55M
5
BA icon
Boeing
BA
+$1.28M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.28M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.12M
3
WFC icon
Wells Fargo
WFC
+$1.43M
4
ABBV icon
AbbVie
ABBV
+$917K
5
FDX icon
FedEx
FDX
+$843K

Sector Composition

Rank Sector Weight
1 Healthcare 19.73%
2 Industrials 14.53%
3 Technology 14.16%
4 Financials 14.05%
5 Energy 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACGL icon
201
Arch Capital
ACGL
$33.6B
$224K 0.02%
+6,930
New +$211K
CAH icon
202
Cardinal Health
CAH
$55.4B
$223K 0.02%
4,632
CDK
203
DELISTED
CDK Global, Inc.
CDK
$216K 0.02%
+3,667
New +$200K
XBI icon
204
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$215K 0.02%
+2,375
New +$202K
MER.PRK
205
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$209K 0.02%
8,000
CHD icon
206
Church & Dwight Co
CHD
$24.5B
$208K 0.02%
+2,920
New +$192K
ALB icon
207
Albemarle
ALB
$15.5B
$205K 0.02%
+2,500
New +$204K
NFLX icon
208
Netflix
NFLX
$309B
$201K 0.02%
+5,630
New +$195K
NRT
209
North European Oil Royalty Trust
NRT
$81M
$201K 0.02%
29,199
BBT.PRE.CL
210
DELISTED
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
$201K 0.02%
+8,000
New +$199K
MRKR icon
211
Marker Therapeutics
MRKR
$18.7M
$199K 0.02%
3,010
OVV icon
212
Ovintiv
OVV
$16.4B
$105K 0.01%
+2,895
New +$99.3K
CVE icon
213
Cenovus Energy
CVE
$52.1B
$102K 0.01%
11,725
-1,000
-8% -$8.3K
WHWK
214
Whitehawk Therapeutics
WHWK
$271M
$90K 0.01%
6,667
MTNB icon
215
Matinas BioPharma
MTNB
$1.81M
$19K ﹤0.01%
350
HGT
216
DELISTED
Hugoton Royalty Trust
HGT
$9K ﹤0.01%
17,500
CNC icon
217
Centene
CNC
$32.5B
-4,000
Closed -$231K
MS icon
218
Morgan Stanley
MS
$340B
-7,200
Closed -$286K
SHPG
219
DELISTED
Shire pic
SHPG
-4,627
Closed -$806K

Similar funds

Neville Rodie & Shaw's Q1 2019 Portfolio in Review

As of Q1 2019, Neville Rodie & Shaw held 256 positions worth $944M, up 14% from $824M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q1 2019 filing shows 19 new, 59 increased, 92 reduced and 3 closed positions. Its largest new stake was Marathon Oil Corporation: 30,176 shares worth $505K. The largest sale was JPMorgan Chase, an estimated $2.28M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • Neville Rodie & Shaw's largest Q1 2019 buy was Marathon Oil Corporation: 30,176 shares worth $505K.
  • Neville Rodie & Shaw added most to UnitedHealth in Q1 2019, an estimated $5.03M increase.
  • Neville Rodie & Shaw's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $2.28M.
  • Neville Rodie & Shaw fully exited Shire pic in Q1 2019, selling an estimated $806K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $944M portfolio in Q1 2019.
  • Neville Rodie & Shaw opened 19 new positions and closed 3 in Q1 2019.
  • Neville Rodie & Shaw's portfolio value rose 14% quarter-over-quarter to $944M.

Based on Neville Rodie & Shaw's 13F filing for Q1 2019, filed 8 Apr 2019.